Cancers, Год журнала: 2025, Номер 17(5), С. 722 - 722

Опубликована: Фев. 20, 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging as a leading cause of chronic disease. In recent years, artificial intelligence (AI) has attracted significant attention in healthcare, particularly diagnostics, patient management, and drug development, demonstrating immense potential for application implementation. the field MASLD, substantial research explored AI various areas, including counseling, improved stratification, enhanced diagnostic accuracy, prognosis prediction. However, integration hepatology not without challenges. Key issues include data management privacy, algorithmic bias, risk AI-generated inaccuracies, commonly referred to "hallucinations". This review aims provide comprehensive overview applications hepatology, with focus on highlighting both its transformative inherent limitations.

Язык: Английский